These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 16419072

  • 21. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
    van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, van der Pol MA, Waisfisz Q, Ossenkoppele GJ, Schuurhuis GJ.
    Clin Cancer Res; 2005 Sep 15; 11(18):6520-7. PubMed ID: 16166428
    [Abstract] [Full Text] [Related]

  • 22. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings.
    Voskova D, Schoch C, Schnittger S, Hiddemann W, Haferlach T, Kern W.
    Cytometry B Clin Cytom; 2004 Nov 15; 62(1):25-38. PubMed ID: 15468339
    [Abstract] [Full Text] [Related]

  • 23. The role of multiparameter flow cytometry for disease monitoring in AML.
    Kern W, Bacher U, Haferlach C, Schnittger S, Haferlach T.
    Best Pract Res Clin Haematol; 2010 Sep 15; 23(3):379-90. PubMed ID: 21112037
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X.
    Cancer; 2008 Feb 01; 112(3):572-80. PubMed ID: 18085638
    [Abstract] [Full Text] [Related]

  • 25. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I, Beason K, Yu C, Hughson M.
    Cancer Genet Cytogenet; 2005 Nov 01; 163(1):62-7. PubMed ID: 16271957
    [Abstract] [Full Text] [Related]

  • 26. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.
    Ruiz-Argüelles GJ, Fernández-Lara D, Estrada-Gómez R, Manzano C, Ruiz-Delgado GJ, Pérez-Romano B, Ruiz-Argüelles A.
    Lab Hematol; 2007 Nov 01; 13(1):22-6. PubMed ID: 17353179
    [Abstract] [Full Text] [Related]

  • 27. Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
    Verstovsek S, Manshouri T, Smith FO, Giles FJ, Cortes J, Estey E, Kantarjian H, Keating M, Jeha S, Albitar M.
    Cancer; 2003 May 01; 97(9):2212-7. PubMed ID: 12712473
    [Abstract] [Full Text] [Related]

  • 28. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry.
    Zelezníková T, Babusíková O.
    Neoplasma; 2005 May 01; 52(6):517-22. PubMed ID: 16284699
    [Abstract] [Full Text] [Related]

  • 29. Combined analysis of bcl-2 and MDR1 proteins in 256 cases of acute myeloid leukemia.
    Venditti A, Del Poeta G, Maurillo L, Buccisano F, Del Principe MI, Mazzone C, Tamburini A, Cox C, Panetta P, Neri B, Ottaviani L, Amadori S.
    Haematologica; 2004 Aug 01; 89(8):934-9. PubMed ID: 15339676
    [Abstract] [Full Text] [Related]

  • 30. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
    Maurillo L, Buccisano F, Del Principe MI, Del Poeta G, Spagnoli A, Panetta P, Ammatuna E, Neri B, Ottaviani L, Sarlo C, Venditti D, Quaresima M, Cerretti R, Rizzo M, de Fabritiis P, Lo Coco F, Arcese W, Amadori S, Venditti A.
    J Clin Oncol; 2008 Oct 20; 26(30):4944-51. PubMed ID: 18606980
    [Abstract] [Full Text] [Related]

  • 31. Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests.
    Díez-Martín JL, Buño I, Llamas P, Gosálvez J, López-Fernández C, Polo N, Regidor C.
    Cancer Detect Prev; 2000 Oct 20; 24(2):169-72. PubMed ID: 10917138
    [Abstract] [Full Text] [Related]

  • 32. Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients.
    Perea G, Domingo A, Villamor N, Palacios C, Juncà J, Torres P, Llorente A, Fernández C, Tormo M, Queipo de Llano MP, Bargay J, Gallart M, Florensa L, Vivancos P, Martí JM, Font L, Berlanga J, Esteve J, Bueno J, Ribera JM, Brunet S, Sierra J, Nomdedéu JF, CETLAM GroupSpain.
    Leuk Res; 2005 Oct 20; 29(10):1109-16. PubMed ID: 16095690
    [Abstract] [Full Text] [Related]

  • 33. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH, Choi SJ, Lee JH, Park JH, Kim H, Joo YD, Lee WS, Zang DY, Kim HJ, Lee KH, Cooperative Study Group A for Hematology.
    Ann Hematol; 2006 Jun 20; 85(6):357-65. PubMed ID: 16575580
    [Abstract] [Full Text] [Related]

  • 34. Modern diagnostics in acute leukemias.
    Haferlach T, Kern W, Schnittger S, Schoch C.
    Crit Rev Oncol Hematol; 2005 Nov 20; 56(2):223-34. PubMed ID: 16213152
    [Abstract] [Full Text] [Related]

  • 35. Monitoring of minimal residual disease in acute myeloid leukemia.
    Kern W, Haferlach C, Haferlach T, Schnittger S.
    Cancer; 2008 Jan 01; 112(1):4-16. PubMed ID: 18000811
    [Abstract] [Full Text] [Related]

  • 36. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.
    Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U, Reinhardt D.
    Cytometry B Clin Cytom; 2005 Jan 01; 63(1):1-9. PubMed ID: 15624201
    [Abstract] [Full Text] [Related]

  • 37. [A minimal residual population of leukemic cells in patients with acute myeloid leukemias].
    Gal'tseva IV, Parovichnikova EN, Savchenko VG.
    Ter Arkh; 1997 Jan 01; 69(7):74-9. PubMed ID: 9424769
    [No Abstract] [Full Text] [Related]

  • 38. Detection of minimal residual disease in an AML patient with trisomy 8 using interphase fish.
    White DL, Hutchins CJ, Turczynowicz S, Suttle J, Haylock DN, Hughes TP, Juttner CA, To LB.
    Pathology; 1997 Aug 01; 29(3):289-93. PubMed ID: 9271020
    [Abstract] [Full Text] [Related]

  • 39. [Immunophenotyping with flow cytometry in patients with acute leukemia].
    Mociková H, Mociková K, Wildová B, Kohútová M, Bubanská E.
    Vnitr Lek; 1996 Jul 01; 42(7):454-7. PubMed ID: 8928420
    [Abstract] [Full Text] [Related]

  • 40. Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance.
    Bahia DM, Yamamoto M, Chauffaille Mde L, Kimura EY, Bordin JO, Filgueiras MA, Kerbauy J.
    Haematologica; 2001 Aug 01; 86(8):801-6. PubMed ID: 11522535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.